At the USCAP annual conference in Baltimore, MD, from March 25-28, 2024, Pramana, Inc. will exhibit its advanced solutions for Digital Pathology 2.0 at booth #549. Pramana will showcase its vast experience and cutting-edge technologies, such as the development of…
Castle Biosciences, Inc. (Nasdaq: CSTL), a company focused on improving patient care through innovative tests, has announced the presentation of new data showcasing the performance of its DecisionDx-Melanoma test in predicting the risk of sentinel lymph node (SLN) positivity in…
Daiichi Sankyo Europe GmbH and Esperion Therapeutics, Inc. have made a joint announcement regarding the recent developments related to bempedoic acid (marketed as NILEMDO®) and the bempedoic acid/ezetimibe fixed combination tablet (marketed as NUSTENDI®) in the European market. The Committee…
Esperion (NASDAQ: ESPR) announced today that the FDA has approved expanded labels for NEXLETOL® (bempedoic acid) Tablets and NEXLIZET® (bempedoic acid and ezetimibe) Tablets. This approval is based on positive CLEAR Outcomes data and includes indications for cardiovascular risk reduction…
Meridian Health Plan of Illinois, Inc. (Meridian), a company that provides managed care services under government sponsorship to various segments of the population such as families, children, seniors, and individuals with complex medical needs, announced today that it will offer…
Superior HealthPlan, a key managed care organization in Texas and a subsidiary of Centene Corporation, has released its annual community investment report. The report underscores Superior’s dedication to enhancing the well-being of individuals and families across the state. In 2023,…
UnitedHealth Group (NYSE: UNH) is making strides in addressing the impact of the recent cyberattack on the U.S. health system and Change Healthcare services. The company is expanding financial support for affected providers while taking steps to restore services. Change…
Spectrum Solutions®, a leading saliva diagnostic biotech company, has launched SimplyPERIO™, a new saliva diagnostic testing solution. This innovative test addresses the growing focus on the mouth-body connection and its impact on overall health. SimplyPERIO™ offers comprehensive health insights by…
The Advanced Brain + Body Clinic Ketamine TMS (AB+BC), experts in addressing treatment-resistant depression and severe mental health disorders, has included Vagus Nerve Stimulation (VNS) in its treatment options. VNS, approved by the FDA, is a non-medication therapy suitable for…
VISTA.AI has named Daniel Hawkins as its new President and CEO. The company specializes in AI-driven MRI image acquisition, aiming to enable MRI technicians to generate high-quality scans efficiently and affordably for various complex indications. Daniel’s appointment comes at a…
ImpriMed, a top precision medicine startup using AI for cancer treatment advancement, shared its participation in the World Veterinary Cancer Congress (WVCC) 2024 in Tokyo, Japan, from March 21-24, 2024. CEO Dr. Sungwon Lim and CTO Dr. Jamin Koo will…
PocketHealth, the leader in patient-centric medical image exchange, today announced it has raised $33 million USD ($45 million CAD) in Series B funding. The all-equity round was led by Round13 Capital with participation from Deloitte Ventures, Samsung Next, and existing…